COLL vs DASH
Collegium Pharmaceutical Inc (COLL) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the COLL and DASH stock pages for the full models.
Not investment advice.